---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-074022"
form_type: "8-K"
ticker: "ENOV"
cik: "0001420800"
company_name: "Enovis CORP"
filed_at: "2022-03-14T23:59:59+00:00"
generated_at: "2026-06-26T23:08:55.492265+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Colfax schedules investor meetings for planned separation of ESAB, rename to Enovis

## Summary
- Virtual investor meetings held March 14, 2022 for Colfax and ESAB.
- Separation to create two independent public companies: Enovis (medical tech) and ESAB (fabrication tech).
- Post-separation, Colfax will be renamed Enovis Corporation and continue medical technology business.
- Investor presentations furnished as Exhibits 99.1 and 99.2.

## SEC filing metadata
- accession: 0001193125-22-074022
- form_type: 8-K
- ticker: ENOV
- cik: 0001420800
- company_name: Enovis CORP
- filed_at: 2022-03-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1420800/000119312522074022/0001193125-22-074022-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1420800/000119312522074022/d312247d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-074022
- JSON: https://secwatch.observer/filing/0001193125-22-074022.json
- Plain text: https://secwatch.observer/filing/0001193125-22-074022.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.